Andrea Simon
Nurse Practitioner · Newark, DENPI 1790176113
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 17 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 9 manufacturers, the largest accounting for just 21.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $345 and has fallen 55.5% since, to $153 in 2025.
Across 17 payments — averaging $37.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$139
- Haemonetics Corporation$132
- Johnson & Johnson$93
- Solventum Corporation$65
- Teleflex LLC$64
- AstraZeneca$49
- plus $103 from 3 others
What the payments were for
- Food & beverage$646100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 5 | $139 |
| Haemonetics Corporation | 2 | $132 |
| Johnson & Johnson | 1 | $93 |
| Solventum Corporation | 2 | $65 |
| Teleflex LLC | 2 | $64 |
| AstraZeneca | 1 | $49 |
| Polynovo North America LLC | 1 | $38 |
| Avita Medical Americas, LLC | 1 | $33 |
| KCI USA, Inc. | 2 | $32 |
How this compares
$646 in reported general payments places this provider in the 70th percentile of 487 nurse practitioner providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 17 | $59 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Newark
- Sedelle Henderson-BamideleNewark$13K
- Funmilola OlaoyeNewark$7K
- Lyron DeputyNewark$6K
- Mark LandisNewark$5K
- Noreen Murphy BowensNewark$4K
- Mary ZimnyNewark$4K
- Amanda WardwellNewark$4K
- Heather DennisNewark$4K
- Anesha VictorNewark$3K
- Lori GrantNewark$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.